Access to Symmetrical and Unsymmetrical Cyclobutanes via Template-Directed [2+2]-Photodimerization Reactions of Cinnamic Acids
Synthesis · 16.11.2023 · 55 (22) · 3777-3792
DOI: 10.1055/a-2126-3774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 16.11.2023. Verfasst von Yunus Emre Türkmen und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Türkiye Bilimler Akademisi.
Abstract (Originalsprache)
In this work, we have developed a general and broadly applicable template-directed photochemical [2+2]-cycloaddition reaction which provides access to a wide range of symmetrical and unsymmetrical cyclobutane products. The use of 1,8-dihydroxynaphthalene as a covalent template paved the way for successful and highly selective photochemical homodimerization and heterodimerization reactions in the solid state between cinnamic acid derivatives. Notably, the method works equally well with aryl- and heteroaryl-containing substrates leading to the formation of β-truxinic acid analogues as single diastereomers and in high yields (up to 99%).
Förderung
- Türkiye Bilimler Akademisi
Zitieren
APA
Türkmen, Y. E., Yagci, B. B., Munir, B., & Zorlu, Y. (2023). Access to Symmetrical and Unsymmetrical Cyclobutanes via Template-Directed [2+2]-Photodimerization Reactions of Cinnamic Acids. Synthesis, 55(22), 3777-3792. https://doi.org/10.1055/a-2126-3774
Vancouver
Türkmen YE, Yagci BB, Munir B, Zorlu Y. Access to Symmetrical and Unsymmetrical Cyclobutanes via Template-Directed [2+2]-Photodimerization Reactions of Cinnamic Acids. Synthesis. 2023;55(22):3777-3792. doi:10.1055/a-2126-3774
BibTeX
@article{Trkmen2023,
author = {Türkmen, Yunus Emre and Yagci, Bilge Banu and Munir, Badar and Zorlu, Yunus},
title = {Access to Symmetrical and Unsymmetrical Cyclobutanes via Template-Directed [2+2]-Photodimerization Reactions of Cinnamic Acids},
journal = {Synthesis},
year = {2023},
volume = {55},
number = {22},
pages = {3777--3792},
doi = {10.1055/a-2126-3774}
}
EUVIMED